| Literature DB >> 31027996 |
James Meixiong1, Michael Anderson1, Nathachit Limjunyawong1, Mark F Sabbagh1, Eric Hu1, Madison R Mack2, Landon K Oetjen2, Fang Wang2, Brian S Kim3, Xinzhong Dong4.
Abstract
Classical itch studies have focused on immunoglobulin E (IgE)-mediated mast cell activation and histamine release. Recently, members of the Mas-related G-protein-coupled receptor (Mrgpr) family have been identified as mast cell receptors, but their role in itch is unclear. Here, we report that mast cell activation via Mrgprb2 evoked non-histaminergic itch in mice independently of the IgE-Fc epsilon RI (FcεRI)-histamine axis. Compared with IgE-FcεRI stimulation, Mrgprb2 activation of mast cells was distinct in both released substances (histamine, serotonin, and tryptase) and the pattern of activated itch-sensory neurons. Mrgprb2 deficiency decreased itch in multiple preclinical models of allergic contact dermatitis (ACD), a pruritic inflammatory skin disorder, and both mast cell number and PAMP1-20 concentrations (agonist of the human Mrgprb2 homolog, MRGPRX2) were increased in human ACD skin. These findings suggest that this pathway may represent a therapeutic target for treating ACD and mast-cell-associated itch disorders in which antihistamines are ineffective.Entities:
Keywords: GPCR; MRGPRX2; Mrgpr; Mrgprb2; histamine; itch; mast cell; pruritus; receptor
Mesh:
Substances:
Year: 2019 PMID: 31027996 PMCID: PMC6531358 DOI: 10.1016/j.immuni.2019.03.013
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745